BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Han SW, Roman J. Anticancer actions of PPARγ ligands: Current state and future perspectives in human lung cancer. World J Biol Chem 2010; 1(3): 31-40 [PMID: 21537367 DOI: 10.4331/wjbc.v1.i3.31]
URL: https://www.wjgnet.com/1949-8454/full/v1/i3/31.htm
Number Citing Articles
Tuyen N. M. Hua, Jun Namkung, Ai N. H. Phan, Vu T. A. Vo, Min-Kyu Kim, Yangsik Jeong, Jong-Whan Choi. PPARgamma-mediated ALDH1A3 suppression exerts anti-proliferative effects in lung cancer by inducing lipid peroxidationJournal of Receptors and Signal Transduction 2018; 38(3): 191 doi: 10.1080/10799893.2018.1468781
Han Zhao, Huihui Gu, Han Zhang, Jun-Hui Li, Wen-En Zhao. PPARγ-dependent pathway in the growth-inhibitory effects of K562 cells by carotenoids in combination with rosiglitazoneBiochimica et Biophysica Acta (BBA) - General Subjects 2014; 1840(1): 545 doi: 10.1016/j.bbagen.2013.09.005
Jingjing Li, Yi-Ping Liu. The roles of PPARs in human diseasesNucleosides, Nucleotides & Nucleic Acids 2018; 37(7): 361 doi: 10.1080/15257770.2018.1475673
Ting Zhao, Hong Du, Janice S. Blum, Cong Yan. Critical role of PPARγ in myeloid-derived suppressor cell-stimulated cancer cell proliferation and metastasisOncotarget 2016; 7(2): 1529 doi: 10.18632/oncotarget.6414
Łukasz Uram, Aleksandra Filipowicz, Maria Misiorek, Natalia Pieńkowska, Joanna Markowicz, Elżbieta Wałajtys-Rode, Stanisław Wołowiec. Biotinylated PAMAM G3 dendrimer conjugated with celecoxib and/or Fmoc-l-Leucine and its cytotoxicity for normal and cancer human cell linesEuropean Journal of Pharmaceutical Sciences 2018; 124: 1 doi: 10.1016/j.ejps.2018.08.019
Monica Mangoni, Mariangela Sottili, Chiara Gerini, Pierluigi Bonomo, Anna Bottoncetti, Francesca Castiglione, Ciro Franzese, Sara Cassani, Daniela Greto, Tatiana Masoni, Icro Meattini, Stefania Pallotta, Alessandro Passeri, Alberto Pupi, Eleonora Vanzi, Giampaolo Biti, Lorenzo Livi. A PPAR-gamma agonist attenuates pulmonary injury induced by irradiation in a murine modelLung Cancer 2015; 90(3): 405 doi: 10.1016/j.lungcan.2015.11.005
Mohamed A. Abdelgawad, Khaled El-Adl, Sanadelaslam S. A. El-Hddad, Mostafa M. Elhady, Nashwa M. Saleh, Mohamed M. Khalifa, Fathalla Khedr, Mohamed Alswah, AbdElAziz A. Nayl, Mohammed M. Ghoneim, Nour E. A. Abd El-Sattar. Design, Molecular Docking, Synthesis, Anticancer and Anti-Hyperglycemic Assessments of Thiazolidine-2,4-diones Bearing Sulfonylthiourea Moieties as Potent VEGFR-2 Inhibitors and PPARγ AgonistsPharmaceuticals 2022; 15(2): 226 doi: 10.3390/ph15020226
Tae Woo Kim, Da-Won Hong, Chang-Mo Kang, Sung Hee Hong. A novel PPARɣ ligand, PPZ023, overcomes radioresistance via ER stress and cell death in human non-small-cell lung cancer cellsExperimental & Molecular Medicine 2020; 52(10): 1730 doi: 10.1038/s12276-020-00511-9